Best Antibiotic for Pneumonia
For outpatient community-acquired pneumonia in healthy adults without comorbidities, amoxicillin 1 gram three times daily for 5-7 days is the first-line treatment, with doxycycline 100 mg twice daily as the preferred alternative. 1, 2
Outpatient Treatment Algorithm
Healthy Adults Without Comorbidities (No Recent Antibiotics)
First-line choice:
- Amoxicillin 1 gram orally every 8 hours for 5-7 days 1, 2
- This targets Streptococcus pneumoniae, the most common pathogen (accounts for 48% of identified cases and two-thirds of bacteremic pneumonia) 1, 2
Alternative options:
- Doxycycline 100 mg orally twice daily for 5-7 days 1, 2
- Macrolide monotherapy (azithromycin 500 mg day 1, then 250 mg daily for 4 days OR clarithromycin 500 mg twice daily) ONLY if local pneumococcal macrolide resistance is documented <25% 1, 3, 2
Critical caveat: Macrolide monotherapy should be avoided in most settings due to widespread resistance (>25% in many regions) and risk of breakthrough pneumococcal bacteremia with resistant strains 2
Adults With Comorbidities or Recent Antibiotic Use (Within 90 Days)
Combination therapy is mandatory:
- Amoxicillin-clavulanate 1-2 grams orally every 12 hours PLUS azithromycin 500 mg day 1, then 250 mg daily for 5-7 days 1, 2
- Alternative: Cefuroxime, cefpodoxime, or cefaclor PLUS macrolide 1
Fluoroquinolone monotherapy alternative:
- Levofloxacin 750 mg orally once daily for 5 days 1, 2
- Moxifloxacin 400 mg orally once daily for 5-7 days 1
- Warning: Reserve fluoroquinolones for patients who cannot use other options due to risks of tendinopathy, peripheral neuropathy, and CNS effects 2
Key principle: If antibiotics were used in the prior 90 days, select a different antibiotic class to reduce resistance risk 2
Hospitalized Non-ICU Patients
Preferred regimen:
- Ceftriaxone 1-2 grams IV once daily OR cefotaxime 1-2 grams IV every 8 hours PLUS azithromycin 500 mg IV/PO once daily OR clarithromycin 500 mg IV/PO twice daily 1, 2
- Alternative: Ampicillin-sulbactam 1.5-3 grams IV every 6 hours PLUS macrolide 1
Fluoroquinolone monotherapy alternative:
Duration: 5-7 days for most cases 1, 2
Severe Pneumonia (ICU Patients)
Mandatory combination therapy:
- β-lactam (ceftriaxone 2 grams IV daily, cefotaxime 2 grams IV every 8 hours, ampicillin-sulbactam 3 grams IV every 6 hours, OR piperacillin-tazobactam) PLUS either azithromycin 500 mg IV daily OR levofloxacin 750 mg IV daily 1
Never use fluoroquinolone monotherapy in ICU patients 1
Extended duration: 10 days for severe pneumonia; extend to 14-21 days if Legionella, Staphylococcus aureus, or gram-negative enteric bacilli are suspected or confirmed 1, 2
Hospital-Acquired Pneumonia (HAP)
Low Risk (No MRSA Risk Factors, Not High Mortality Risk)
Monotherapy options:
- Piperacillin-tazobactam 4.5 grams IV every 6 hours 1
- Cefepime 2 grams IV every 8 hours 1
- Levofloxacin 750 mg IV daily 1
- Imipenem 500 mg IV every 6 hours OR meropenem 1 gram IV every 8 hours 1
High Risk (MRSA Risk Factors or High Mortality Risk)
Combination therapy required:
- Two antipseudomonal agents from different classes (avoid two β-lactams) PLUS MRSA coverage 1
- MRSA coverage: Vancomycin 15 mg/kg IV every 8-12 hours (target trough 15-20 mg/mL) OR linezolid 600 mg IV every 12 hours 1
MRSA risk factors include: IV antibiotics within 90 days, unit where >20% of S. aureus isolates are methicillin-resistant, or prior MRSA detection 1
Pediatric Pneumonia
Children Under 3 Years
First-line:
- Amoxicillin 80-100 mg/kg/day orally in 3 divided doses for 10 days 1
- Rationale: Pneumococcus is the predominant bacterial pathogen in this age group 1
If inadequate Hib vaccination (<3 doses) OR concurrent purulent otitis media:
- Amoxicillin-clavulanate 80 mg/kg/day (amoxicillin component) 1
Children Over 3 Years
If pneumococcal pneumonia suspected (lobar consolidation):
- Amoxicillin 80-100 mg/kg/day orally in 3 divided doses for 10 days 1
If atypical pneumonia suspected (Mycoplasma or Chlamydophila):
- Azithromycin 10 mg/kg day 1, then 5 mg/kg days 2-5 1
- Alternative: Clarithromycin 15 mg/kg/day divided twice daily for 14 days 1
Critical Treatment Principles
Assessment of clinical response:
- Evaluate at 48-72 hours (hospitalized) or 5-7 days (outpatients) 2
- Fever should resolve within 2-4 days; pneumococcal pneumonia often responds within 24 hours 1, 2
- Chest radiograph changes lag behind clinical improvement; do not repeat imaging in responding patients 1
Failure to respond indicates:
- Incorrect diagnosis, host failure, inappropriate antibiotic selection, resistant pathogen, adverse drug reaction, or complication (empyema, abscess) 1
- For non-severe pneumonia on amoxicillin monotherapy: add or substitute macrolide 1
- For non-severe pneumonia on combination therapy: switch to respiratory fluoroquinolone 1
- For severe pneumonia not responding: consider adding rifampicin 1
Switch from IV to oral therapy when:
- Clinical improvement evident 1
- Hemodynamically stable 1
- Able to ingest medications 1
- Typically occurs within 3-5 days 1
Common pitfalls to avoid:
- Using macrolide monotherapy in areas with >25% pneumococcal macrolide resistance 2
- Using macrolide monotherapy in patients with any comorbidities 2
- Using fluoroquinolone monotherapy in ICU patients 1
- Failing to cover MRSA in high-risk HAP patients 1
- Using azithromycin or other macrolides in patients who received them within 90 days 2